Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
For Investors
>
Corporate Presentations
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Corporate Presentations
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
12-Nov-2021
Kazia Therapeutics AGM 2021
16-Aug-2021
Kazia corporate presentation
21-Apr-2021
EVT801 in-licensing deal investor conference call recording
21-Apr-2021
EVT801 in-licensing deal investor conference call transcript
19-Apr-2021
Kazia Corporate Presentation
22-Jan-2021
Kazia presents to ShareCafe Hidden Gems webinar
5-Jan-2021
Kazia presents to HCW BIOCONNECT
1
